This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ISABEL TALIAFERRO, M.D.; EDWIN J. WELLS, M.D.; SAUL KAY, M.D.; RANDOLPH H. HOGE, M.D.

AMA Arch Intern Med. 1953;91(5):675-684.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

OVARIAN tumors which are known to produce masculinization have usually been classified as arrhenoblastomas of the ovary, adrenal-like tumors of the ovary, and luteomas. The relationship of these tumors to each other, especially as regards histogenesis, morphology, and endocrine function, is a matter of continuing discussion, but these relationships remain unsettled. Teilum¹ has emphasized the need for an improved histogenetic and morphologic classification of these and other functioning ovarian neoplasms.

Another ovarian lesion associated with virilization, namely, hyperplasia or tumor of ovarian hilus cells, has recently been studied by Sternberg² and discussed by Schiller.³ The ovarian hilus cells have been called sympathicotropic cells, ovarian Leydig cells, ovarian interstitial cells, and extraglandular Leydig cells; they are morphologically indistinguishable from testicular interstitial cells of Leydig (which produce androgen in the male) and are considered to be a possible source of ovarian androgen.²

Cases of tumor of ovarian hilus cells have been reported . . . [Full Text PDF of this Article]

Author Affiliations
RICHMOND, VA.

From the Departments of Medicine, Gynecology, and Surgical Pathology, Medical College of Virginia and from the Medical College of Virginia Hospitals, Richmond, Va.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?